Skip to content
Research Article Open access CC BY 4.0

Nursing Skill and Responsibility in Administration of Injection Actilyse

Mayur B. Wanjari, Deeplata Mendhe, Pratibha Wankhede

Journal of Pharmaceutical Research International · pp. 151–155 · Published 14 Dec 2021

10.9734/jpri/2021/v33i57B34039

Abstract

Actilyse can break blood clots that form in the heart, blood arteries, or lungs during a heart attack. This medication is also given to stroke patients to improve recovery and reduce the likelihood of impairment. Recombinant DNA technology was used to create Activase, a tissue plasminogen activator. It is a sterile, purified glycoprotein of 527 amino acids. It is made by combining complementary DNA (cDNA) from a human melanoma cell line with the natural human tissue-type plasminogen activator. After reconstitution with Sterile Water for Injection, USP, Activase is a sterile, white to off-white lyophilized powder for intravenous injection.

Actilyse stroke activase glycoprotein lyophilized powder

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

21

Page views

0

PDF downloads

3

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.